Unresolved disorder model. using A ATOM 90 CA AGLN 19 -1.387 -32.884 6.526 0.50 58.53 C Unresolved disorder model. using A ATOM 91 CB AGLN 19 -2.859 -33.057 6.130 0.50 59.51 C Unresolved disorder model. using A ATOM 92 CG AGLN 19 -3.073 -33.876 4.862 0.50 63.11 C Unresolved disorder model. using A ATOM 93 CD AGLN 19 -2.569 -35.301 4.994 0.50 67.46 C Unresolved disorder model. using A ATOM 94 OE1AGLN 19 -3.076 -36.080 5.803 0.50 69.39 O Unresolved disorder model. using A ATOM 95 NE2AGLN 19 -1.563 -35.648 4.196 0.50 63.75 N Unresolved disorder model. using A ATOM 96 CA BGLN 19 -1.389 -32.878 6.523 0.50 57.98 C Unresolved disorder model. using A ATOM 97 CB BGLN 19 -2.857 -33.031 6.104 0.50 58.65 C Unresolved disorder model. using A ATOM 98 CG BGLN 19 -3.073 -32.867 4.598 0.50 59.51 C Unresolved disorder model. using A ATOM 99 CD BGLN 19 -4.496 -32.489 4.230 0.50 61.54 C Unresolved disorder model. using A ATOM 100 OE1BGLN 19 -4.806 -31.315 4.014 0.50 57.99 O Unresolved disorder model. using A ATOM 101 NE2BGLN 19 -5.368 -33.489 4.144 0.50 56.06 N Unresolved disorder model. using A ATOM 590 CA ATRP 86 -2.121 -24.612 12.258 0.50 44.43 C Unresolved disorder model. using A ATOM 591 CB ATRP 86 -2.564 -25.113 10.874 0.50 46.62 C Unresolved disorder model. using A ATOM 592 CG ATRP 86 -3.984 -25.573 10.665 0.50 51.33 C Unresolved disorder model. using A ATOM 593 CD1ATRP 86 -4.926 -24.965 9.883 0.50 56.51 C Unresolved disorder model. using A ATOM 594 CD2ATRP 86 -4.593 -26.776 11.157 0.50 55.44 C Unresolved disorder model. using A ATOM 595 NE1ATRP 86 -6.089 -25.693 9.887 0.50 56.80 N Unresolved disorder model. using A ATOM 596 CE2ATRP 86 -5.911 -26.809 10.661 0.50 55.89 C Unresolved disorder model. using A ATOM 597 CE3ATRP 86 -4.160 -27.815 11.982 0.50 58.38 C Unresolved disorder model. using A ATOM 598 CZ2ATRP 86 -6.798 -27.837 10.967 0.50 56.84 C Unresolved disorder model. using A ATOM 599 CZ3ATRP 86 -5.045 -28.838 12.281 0.50 54.43 C Unresolved disorder model. using A ATOM 600 CH2ATRP 86 -6.344 -28.840 11.777 0.50 54.99 C Unresolved disorder model. using A ATOM 601 CA BTRP 86 -2.084 -24.599 12.452 0.50 42.50 C Unresolved disorder model. using A ATOM 602 CB BTRP 86 -2.677 -25.747 11.613 0.50 41.87 C Unresolved disorder model. using A ATOM 603 CG BTRP 86 -3.066 -25.425 10.195 0.50 41.56 C Unresolved disorder model. using A ATOM 604 CD1BTRP 86 -4.333 -25.412 9.668 0.50 44.38 C Unresolved disorder model. using A ATOM 605 CD2BTRP 86 -2.182 -25.123 9.110 0.50 45.34 C Unresolved disorder model. using A ATOM 606 NE1BTRP 86 -4.289 -25.094 8.327 0.50 38.32 N Unresolved disorder model. using A ATOM 607 CE2BTRP 86 -2.979 -24.914 7.963 0.50 43.60 C Unresolved disorder model. using A ATOM 608 CE3BTRP 86 -0.795 -24.997 8.997 0.50 41.82 C Unresolved disorder model. using A ATOM 609 CZ2BTRP 86 -2.430 -24.590 6.728 0.50 42.95 C Unresolved disorder model. using A ATOM 610 CZ3BTRP 86 -0.261 -24.670 7.775 0.50 41.96 C Unresolved disorder model. using A ATOM 611 CH2BTRP 86 -1.073 -24.469 6.658 0.50 40.51 C Unresolved disorder model. using A ATOM 1110 CA AGLU 149 -1.590 -8.027 10.474 0.50 50.88 C Unresolved disorder model. using A ATOM 1111 CB AGLU 149 -2.419 -8.083 9.182 0.50 51.42 C Unresolved disorder model. using A ATOM 1112 CG AGLU 149 -1.832 -7.300 8.012 0.50 53.53 C Unresolved disorder model. using A ATOM 1113 CD AGLU 149 -2.376 -7.763 6.670 0.50 61.36 C Unresolved disorder model. using A ATOM 1114 OE1AGLU 149 -3.366 -8.528 6.659 0.50 64.38 O Unresolved disorder model. using A ATOM 1115 OE2AGLU 149 -1.819 -7.361 5.626 0.50 59.53 O Unresolved disorder model. using A ATOM 1116 CA BGLU 149 -1.551 -7.993 10.508 0.50 50.42 C Unresolved disorder model. using A ATOM 1117 CB BGLU 149 -2.312 -7.862 9.179 0.50 50.60 C Unresolved disorder model. using A ATOM 1118 CG BGLU 149 -1.456 -7.439 7.967 0.50 50.82 C Unresolved disorder model. using A ATOM 1119 CD BGLU 149 -0.593 -6.207 8.218 0.50 52.91 C Unresolved disorder model. using A ATOM 1120 OE1BGLU 149 -1.084 -5.248 8.849 0.50 54.13 O Unresolved disorder model. using A ATOM 1121 OE2BGLU 149 0.584 -6.193 7.785 0.50 49.75 O Unresolved disorder model. using A ATOM 1728 CA AGLU 224 -4.779 -15.240 33.260 0.50 46.61 C Unresolved disorder model. using A ATOM 1729 CB AGLU 224 -5.805 -14.880 32.180 0.50 49.05 C Unresolved disorder model. using A ATOM 1730 CG AGLU 224 -7.255 -15.155 32.618 0.50 50.66 C Unresolved disorder model. using A ATOM 1731 CD AGLU 224 -8.295 -14.426 31.784 0.50 56.78 C Unresolved disorder model. using A ATOM 1732 OE1AGLU 224 -9.234 -13.846 32.375 0.50 60.63 O Unresolved disorder model. using A ATOM 1733 OE2AGLU 224 -8.180 -14.436 30.540 0.50 53.86 O Unresolved disorder model. using A ATOM 1734 CA BGLU 224 -4.785 -15.212 33.209 0.50 45.61 C Unresolved disorder model. using A ATOM 1735 CB BGLU 224 -5.639 -14.733 32.033 0.50 46.93 C Unresolved disorder model. using A ATOM 1736 CG BGLU 224 -6.989 -14.134 32.458 0.50 44.72 C Unresolved disorder model. using A ATOM 1737 CD BGLU 224 -6.854 -12.796 33.167 0.50 42.17 C Unresolved disorder model. using A ATOM 1738 OE1BGLU 224 -6.221 -11.878 32.603 0.50 39.41 O Unresolved disorder model. using A ATOM 1739 OE2BGLU 224 -7.391 -12.662 34.289 0.50 48.38 O Unresolved disorder model. using A ATOM 2422 CA AASP 309 12.772 -50.101 43.096 0.50 48.53 C Unresolved disorder model. using A ATOM 2423 CB AASP 309 11.911 -50.458 44.326 0.50 47.83 C Unresolved disorder model. using A ATOM 2424 CG AASP 309 12.193 -51.875 44.870 0.50 47.22 C Unresolved disorder model. using A ATOM 2425 OD1AASP 309 12.393 -52.822 44.071 0.50 42.04 O Unresolved disorder model. using A ATOM 2426 OD2AASP 309 12.200 -52.040 46.105 0.50 40.99 O Unresolved disorder model. using A ATOM 2427 CA BASP 309 12.789 -50.093 43.000 0.50 50.10 C Unresolved disorder model. using A ATOM 2428 CB BASP 309 11.801 -50.645 44.024 0.50 51.59 C Unresolved disorder model. using A ATOM 2429 CG BASP 309 10.629 -51.357 43.362 0.50 55.00 C Unresolved disorder model. using A ATOM 2430 OD1BASP 309 10.611 -51.434 42.103 0.50 56.64 O Unresolved disorder model. using A ATOM 2431 OD2BASP 309 9.734 -51.841 44.093 0.50 56.80 O Unresolved disorder model. using A ATOM 2511 CA AGLU 319 -0.113 -41.186 40.198 0.50 48.16 C Unresolved disorder model. using A ATOM 2512 CB AGLU 319 -0.469 -42.467 40.962 0.50 48.26 C Unresolved disorder model. using A ATOM 2513 CG AGLU 319 -0.020 -43.760 40.276 0.50 54.19 C Unresolved disorder model. using A ATOM 2514 CD AGLU 319 -0.803 -44.093 39.007 0.50 61.76 C Unresolved disorder model. using A ATOM 2515 OE1AGLU 319 -0.663 -43.362 38.002 0.50 62.32 O Unresolved disorder model. using A ATOM 2516 OE2AGLU 319 -1.542 -45.104 39.006 0.50 62.82 O Unresolved disorder model. using A ATOM 2517 CA BGLU 319 -0.112 -41.200 40.240 0.50 46.68 C Unresolved disorder model. using A ATOM 2518 CB BGLU 319 -0.410 -42.423 41.123 0.50 45.61 C Unresolved disorder model. using A ATOM 2519 CG BGLU 319 -1.842 -42.413 41.686 0.50 44.53 C Unresolved disorder model. using A ATOM 2520 CD BGLU 319 -2.059 -43.376 42.846 0.50 46.81 C Unresolved disorder model. using A ATOM 2521 OE1BGLU 319 -1.330 -44.387 42.955 0.50 47.47 O Unresolved disorder model. using A ATOM 2522 OE2BGLU 319 -2.980 -43.122 43.646 0.50 39.79 O 1